Altimmune
ALT
#7318
Rank
C$0.77 B
Marketcap
C$3.98
Share price
0.36%
Change (1 day)
-27.80%
Change (1 year)

Earnings for Altimmune (ALT)

Earnings in 2026 (TTM): -C$0.13 Billion

According to Altimmune's latest financial reports the company's current earnings are C$0.03 Million. In 2025 the company made an earning of -C$0.13 Billion, an increase over its 2024 earnings that were of -C$0.14 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Altimmune from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.13 Billion0.17%
2025 -C$0.13 Billion-6.61%
2024 -C$0.14 Billion7.48%
2023 -C$0.13 Billion4.17%
2022 -C$0.12 Billion-12.55%
2021 -C$0.14 Billion78.27%
2020 -C$76.83 Million164.65%
2019 -C$29.03 Million-54.59%
2018 -C$63.93 Million-12.95%
2017 -C$73.45 Million-164.04%
2016 C$0.11 B-2506.1%
2015 -C$4.77 Million-65.85%
2014 -C$13.96 Million-15.12%
2013 -C$16.45 Million146.72%
2012 -C$6.67 Million-16.07%
2011 -C$7.95 Million-76.1%
2010 -C$33.23 Million-8.89%
2009 -C$36.47 Million31.17%
2008 -C$27.81 Million549.91%
2007 -C$4.28 Million7.52%
2006 -C$3.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-C$0.33 Billion 151.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-C$25.62 Million-80.07%๐Ÿ‡บ๐Ÿ‡ธ USA